Song Hong Fang — SEC Form 4 filings

SEC reporting owner CIK 2008157. 6 Form 4 filings on record with FilingPulse; latest filed 2025-09-04.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-01-31 to 2025-09-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CG Oncology, Inc. (CGON)Director61 leg · 263,157 sh · $4,999,9837 legs · 1,450,455 sh · $45,379,6319

Form 4 filings — Song Hong Fang

FiledFormIssuerReported transactionsSource
2025-09-044CG Oncology, Inc. (CGON)Sale (S): 69,695 @ $27.60 · Sale (S): 30,105 @ $28.24 · Sale (S): 100 @ $28.96 · Sale (S): 100 @ $28.99EDGAR
2025-06-064CG Oncology, Inc. (CGON)Grant/award (A): 24,165 (derivative) @ $0EDGAR
2024-12-174CG Oncology, Inc. (CGON)Sale (S): 700,000 @ $28EDGAR
2024-10-074CG Oncology, Inc. (CGON)Grant/award (A): 15,600 (derivative) @ $0EDGAR
2024-08-304CG Oncology, Inc. (CGON)Sale (S): 424,210 @ $35.36 · Sale (S): 226,245 @ $35.36EDGAR
2024-01-314CG Oncology, Inc. (CGON)Conversion (C): 350,771 · Conversion (C): 1,011,192 · Conversion (C): 3,930,176 · Purchase (P): 263,157 @ $19 · Conversion (C): 3,344,608 (derivative) · Conversion (C): 6,262,967 (derivative) · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2008157 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →